Quantification of integrated and total HIV-1 DNA after long-term highly active antiretroviral therapy in HIV-1-infected patients

AIDS

Volumn 13, Issue 9, 1999, Pages 1045-1049

  Ibáñez, Angela ^a   Puig, Teresa ^a   Elias, Johannes ^a   Clotet, Bonaventura ^a   Ruiz, Lidia ^a   Martínez, Miguel Angel ^a  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

CD4 T cell; Highly active antiretroviral therapy; HIV 1; Plasma RNA load; Proviral DNA load

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; INDINAVIR; LAMIVUDINE; NUCLEOSIDE ANALOG; PROTEINASE INHIBITOR; RITONAVIR; STAVUDINE; VIRUS DNA; VIRUS RNA;

ARTICLE; CLINICAL ARTICLE; DNA INTEGRATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS LOAD;

ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; DNA, VIRAL; DRUG THERAPY, COMBINATION; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HIV-1; HUMANS; INDINAVIR; PROVIRUSES; REVERSE TRANSCRIPTASE INHIBITORS; RITONAVIR; RNA, VIRAL; VIRAL LOAD;

EID: 0032788917     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199906180-00007     Document Type: Article

References (23)

1. 1. Gulick RM, Mellors JW, Havlir D, et al. Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. N Engl J Med 1997, 337:734-739.
2. 2. Hammer SM, Squires KE, Hughes MD, et al. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. N Engl J Med 1997, 337:725-733.
3. 3. Perelson AS, Essunger P, Cao Y, et al. HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 1997, 271:1582-1586.
4. 4. Wong JK, Hezareh M, Günthard HF, et al. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science 1997, 278:1291-1295.
5. 5. Wong JK, Günthard HF, Havlir DV, et al. Reduction of HIV-1 in blood and lymph nodes following potent antiretroviral therapy and the virologic correlates of treatment failure. Proc Natl Acad Sci USA 1997, 94:12574-12579.
6. 6. Chun TW, Stuyver I, Mizell SB, et al. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. Proc Natl Acad Sci USA 1997, 94:13193-13197.
7. 7. Finzi D, Hermankova M, Pierson T, et al. Identification of a reservoir for HIV-1 in patients on highly active antiviral therapy. Science 1997, 278:1295-1300.
8. 8. Cohen J. Exploring how to get at - and eradicate - hidden HIV. Science 1998, 279:1854-1855.
9. 9. Ho DD. Toward HIV eradication or remission: the tasks ahead. Science 1998, 280:1866-1867.
10. 10. Chun TW, Engel D, Berrey MM, Shea T, Corey L, Fauci AS. Early establishment of a pool of latently infected, resting CD4 T cells during primary HIV-1 infection. Proc Natl Acad Sci USA 1998, 95:8869-8873.
11. 11. Dickover RE, Donovan RM, Goldstein E, et al. Decreases in unintegrated HIV DNA are associated with antiretroviral therapy in AIDS patients. J Acquired Immune Defic Syndr 1992, 5:31-36.
12. 12. Tamalet C, Lafeuillade A, Fantini J, Poggi C, Yahi N. Quantification of HIV-1 viral load in lymphoid and blood cells: assessment during four-drug combination therapy. AIDS 1997, 11:895-901.
13. 13. Bruisten SM, Reiss P, Loeliger AE, et al. Cellular proviral HIV type 1 DNA load persists after long-term RT-inhibitor therapy in HIV type 1 infected persons. AIDS Res Hum Retroviruses 1998, 14:1053-1058.
14. 14. Chun TW, Carruth L, Finzi D, et al. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature 1997, 387:183-188.
15. 15. Arnó A, Ruiz L, Juan M, et al. Impact on the immune system of undetectable plasma HIV-1 RNA for more than 2 years. AIDS 1998, 12:697-704.
16. 16. Schokmel GA, Yerley S, Perrin L. Detection of low HIV-1 RNA levels in plasma. J Acquired Immune Defic Syndr Hum Retroviral 1997, 14:179-183.
17. 17. Jurka J, Schmid CW. A fundamental division in the Alu family of repeated sequences. Proc Natl Acad Sci USA 1988, 85:4775-4778.
18. 18. Rodrigo AG, Coracke PC, Rowhanian K, Mullins JI. Quantitation of target molecules from polymerase chain reaction-based limiting dilution assays. AIDS Res Hum Retroviruses 1997, 13:737-742.
19. 19. Stevens SW, Griffith J. Sequence analysis of the human DNA flanking sites of human immunodeficiency virus type 1 integration. J Virol 1996, 70:6459-6462.
20. 20. Kukrinsky MI, Stanwich TL, Demsey MP, Stevenson M. Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection. Science 1991, 254:423-427.
21. 21. Cavert W, Notermans DW, Staskus K, et al. Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection. Science 1997, 276:960-963.
22. 22. Günthard HF, Wong JF, Ignacio CC, et al. Human immunodeficiency virus replication and genotypic resistance in blood and lymph nodes after a year of potent antiretroviral therapy. J Virol 1997, 72:2422-2428.
23. 23. Chirtopherson C, Sheppard H, Krowka J, et al. Quantification of HIV-1 proviral DNA: the next step to patient monitoring. Fifth Conference on Retroviruses and Opportunistic Infections. Chicago, 1-5 February 1998 [abstract 304].